Teva Pharmaceuticals National Network

advertisement
Teva Pharmaceuticals National Network
of Excellence (NNE) in Neuroscience
Official launch and Call for Proposals
Introduction
The call for proposals described below and in the attachment marks the official launch of
Teva Pharmaceuticals National Network of Excellence in Neurosciences (NNE). The goal of
the NNE is to support and enhance Israeli neuroscience research, with relevance to human
neurological and psychiatric illness, and to further strengthen the capabilities of the Israeli
Neuroscience research community.
Topics of Interest
1.3 The therapeutic areas of neuroscience research that the NNE will focus on:
1.3.3 Neurodegenerative disorders, such as: Multiple Sclerosis (MS), Alzheimer's Disease,
Frontotemporal Dementia, Parkinson's Disease, Huntington's Disease, Amyotrophic lateral
sclerosis (ALS(
1.3.3 Pain
1.3.1 Neuropsychiatric disorders, such as: Depression, Schizophrenia
1.3.3 Other Neurological disorders (including without limitation): Epilepsy, Tourette
Syndrome, Rett Syndrome and Duchenne muscular dystrophy.
1.3 Research areas that will be supported by the NNE (including without limitation):
Disease genetics, biomarkers, animal models, disease pathways, targets and validated
targets, bioinformatics, novel approaches to disease modification, discovery and early
preclinical drug development, in vitro, animal and human studies and basic neuroscience.
Grant Tracks
The NNE will include three award tracks:
)3(Research Grants – of up to $100,000 per year for a period of two (2) years with a
possible renewal/extension for one (1) additional year, at the sole discretion of Teva.
)3(Pre-Doctoral Scholarships – of up to $25,000 to outstanding pre-doctoral graduate
students in neuroscience (for up to 2 years(
)1(Post-Doctoral Fellowships – of up to $35,000 for outstanding post-doctoral students
that are within three years of their doctorate (for up to 2 years(
Note :Preference will be given to applications that involve more than one institution.
Total Budgetary Envelop
Teva is committed to invest up to $15M in the NNE over a period of 5 years
Deadlines
At RDA: 16:00 on 12 March 2013
At Teva: 17:00 on 15 March 2013. Late applications will not be accepted.
Submission Procedure
Applications for Research Grants will be submitted in accordance with the application
form in Appendix A – Neuroscience Research Grants Application Form – of the attached,
for Pre-Doctoral Scholarships form B, and Post-Doctoral Fellowships form C.
Queries
All questions must be addressed first to the contact information below .If necessary,
contact Teva’s Project Manager, Mati Gill at mati.gill@teva.co.il or +972-54-8885292.
Award Ceremony
The selection of the recipients of all awards will be announced at a ceremonial event at
the end of April. The NNE will officially commence on May 1st.3131 ,
Contacts at RDA
Research Liaison Section
Galia Chelets
Budget Section
Tel: 64 72436
chelets@bgu.ac.il
dinaw@bgu.ac.il
64 72431
Engineering
Dina Weitzman
Health (not clinical)
dmeital@bgu.ac.il 64 72444
Humanities and Social Sciences
Meital Dror
Health - clinical
Institutes for Desert Research
rinatso@bgu.ac.il
64 72432
Natural Sciences
Guilford Glazer Business &
Management
Rinat Solomovich
Download